secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001999371-24-003109
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.02, 9.01, 3.02, 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase raises $6M in convertible preferred; Q4 revenue $8M, net loss $2.1M
-----------------------------------------------------------------------------

- Issued 15,000 Series X Preferred shares at $400 each to Strandler, LLC, affiliate of largest shareholder.
- Preferred convertible into 15M common shares at $0.40/share, pending shareholder approval to boost authorized shares to 95M.
- Strandler and Beachcorp extended maturity of three existing loans to October 1, 2025.
- Q4 2023 revenue $8.0M, net loss $2.1M; FY2023 revenue $37.3M, net loss $4.4M (30% from BASF lawsuit legal fees)
- CEO expects 2024 profitable; company had $30M in completed shipments and confirmed purchase orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000199937124003109/0001999371-24-003109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000199937124003109/nanophase-8k_030124.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-003109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer